MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Gender differences in DLB: frequency, clinical presentation and treatment

    S. Garcia-Ptacek, M.G. Kramberger, D. Aarsland (Huddinge, Sweden)

    Objective: To describe demographic and clinical characteristics and use of cholinesterase inhibitors in women and men diagnosed with DLB. Background: DLB seems to be more…
  • 2016 International Congress

    Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson’s disease

    I. Huertas Fernandez, S. Jesus, F.J. Garcia Gomez, J.A. Lojo, I. Bernal Bernal, M. Bonilla Toribio, J.F. Martin Rodriguez, D. Garcia Solis, P. Gomez Garre, P. Mir (Sevilla, Spain)

    Objective: To investigate the role of APOE, MAPT, COMT, SNCA and GBA genes in both striatal dopaminergic denervation and the development of dementia in Parkinson's…
  • 2016 International Congress

    Effects of gender, age and hyposmia on cognitive functions in healthy elderly individuals at risk for Parkinson’s disease: Results from the TREND study

    S. Heinzel, U. Suenkel, F.G. Metzger, E. Schaeffer, B. Roeben, R. Yilmaz, S. Lerche, K. Brockmann, A.K. von Thaler, I. Liepelt-Scarfone, G.W. Eschweiler, A.J. Fallgatter, W. Maetzler, D. Berg (Tübingen, Germany)

    Objective: To evaluate the impact of gender, age and hyposmia on the cognitive performance in memory, language, executive, and visuo-spatial functions to set the stage…
  • 2016 International Congress

    Facial expressivity in Parkinson’s disease (PD) via an examination of smiling behavior: Preliminary findings

    D.L. McCabe, A.D. Bono, R.J. Stafford, A.I. Dumer, K.A. Scorpio, J.L. Spielman, R. Bind, L.O. Ramig, J.C. Borod (New York, NY, USA)

    Objective: The purpose was to examine facial emotional expression in individuals with PD and in healthy control (HC) subjects (Ss) using the Facial Action Coding…
  • 2016 International Congress

    A case of misdiagnosed Parkinson’s disease (PD)

    I. Gabrielyan, K. Harutyunyan, G. Avagyan, H. Amirjanyan, A. Voskanyan, S. Khachaturyan, H. Hambardzumyan, A. Nazaryan, H. Manvelyan (Yerevan, Armenia)

    Objective: Parkinson's disease (PD) is a neurodegenerative disorder affecting the basal ganglia. Parkinsonism is the main syndrome of PD, characterised by bradykinesia, rigidity, rest tremor…
  • 2016 International Congress

    Effects of dual task on upper extremity function and postural control in patients with Parkinson’s disease

    S.M.A.A. Pompeu, B.R.B. Moraes, J.E. Pompeu (São Paulo, Brazil)

    Objective: To verify the performance and pattern of prioritization of patients with Parkinson's disease in motor and cognitive dual tasks with different demands. Background: Patients…
  • 2016 International Congress

    DYT16/PRKRA founder mutation causes childhood-onset generalized dystonia in a family from southern Italy

    M. Quadri, S. Olgiati, M. Sensi, F. Gualandi, E. Groppo, V. Rispoli, J. Graafland, G.J. Breedveld, G. Fabbrini, A. Berardelli, V. Bonifati (Rotterdam, Netherlands)

    Objective: To describe a family with three siblings affected by the combination of dystonia and parkinsonism, as a resulting phenotype of recessive PRKRA mutation. Background:…
  • 2016 International Congress

    The effect of improved nutritional status on psychiatric features and quality of life in Parkinson’s disease patients

    N. Ongun, C. Erdogan, E. Degirmenci, L.S. Bir (Denizli, Turkey)

    Objective: To determine the effect of nutritional status in 6 weeks time on depression, anxiety and quality of life in Parkinson's disease (PD) patients. Background:…
  • 2016 International Congress

    AntiParkinsonian effects of the “radiprodil and tozadenant” combination in MPTP-treated marmosets

    A. Michel, J.M. Nicolas, S. Rose, M. Jackson, P. Colman, W. Briône, D. Sciberras, P. Muglia, D. Scheller, M. Citron, P. Downey (Braine L'Alleud, Belgium)

    Objective: Investigate a combination of two clinically tested drugs, the NR2B antagonist Radiprodil and the A2A antagonist Tozadenant in unilaterally 6-OHDA-lesioned rats and in MPTP-treated…
  • 2016 International Congress

    Validity and reliability of the test d evaluation des membres superieurs de personnes agees (TEMPA) to assess upper limb in Parkinson’s disease

    C.L. Correa, P.R. de-Freitas, A.E. Lemos, S.M. Michaelsen, A. Swarowsky (Rio de Janeiro, Brazil)

    Objective: This study aims to carry out validity and reliability of the Test dEvaluation des Membres Superieurs Des Personnes Agees (TEMPA) in patients with PD.…
  • « Previous Page
  • 1
  • …
  • 369
  • 370
  • 371
  • 372
  • 373
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley